StonvexLoading…
StonvexCore line items from TOL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $10.97B | $10.85B | $9.99B | $10.28B |
Operating Income | $1.72B | $2.04B | $1.72B | $1.51B |
Net Income | $1.35B | $1.57B | $1.37B | $1.29B |
EPS (Diluted) | $13.49 | $15.01 | $12.36 | $10.90 |
Total Assets | $14.52B | $13.37B | $12.53B | $12.29B |
Total Liabilities | $6.23B | $5.68B | $5.71B | $6.27B |
Cash & Equivalents | $1.26B | $1.30B | $1.30B | $1.35B |
Free Cash Flow OCF − CapEx | $1.03B | $936.52M | $1.19B | $915.09M |
Shares Outstanding | 94.80M | 99.80M | 103.80M | 109.60M |